Research progress of artificial blood

doi:10.16352/j.issn.1001-6325.2024.01.0124

Abstract

Abstract: Artificial blood is a type of liquid preparation with oxygen-loading capacity and can temporarily substitute some function of blood. The developed artificial blood can be divided into four categories: artificial synthetic hemoglobin, artificial red blood cells made from natural hemoglobin, perfluorocarbons, and stem cell-differentiated red blood cells. This review focuses on the domestic and foreign research progress of artificial blood in recent years, and discusses its clinical application value, development trend, and future research, in order to provide new ideas to the development the artificial blood products and promote clinical application.

Key words: artificial blood, erythrocyte, hemoglobin

CLC Number:

R977.8

REN Feng, JIN Yishan, CHEN Lu, RONG Long, YU Chunhong. Research progress of artificial blood[J]. Basic & Clinical Medicine, 2024, 44(1): 124-130.

References 25

[1]	于永敬, 汤毅楠, 张媛, 等. 病历质控系统在输血病历中的应用[J]. 基础医学与临床, 2021,41: 1554-1558.
[2]	Kanagarajan S, Carlsson MLR, Chakane S, et al. Production of functional human fetal hemoglobin in Nicotiana benthamiana for development of hemoglobin-based oxygen carriers[J]. Int J Biol Macromol, 2021, 184: 955-966.
[3]	Dewangan HK. Albumin as natural versatile drug carrier for various diseases treatment[M]//Saneja A, Panda AK, Lichtfouse E. Sustainable agriculture reviews 43: pharmaceutical technology for natural products delivery vol. 1 fundamentals and applications. Cham: Springer International Publishing, 2020: 239-268.
[4]	Twyman LJ, Ellis A, Gittins PJ. Pyridine encapsulated hyperbranched polymers as mimetic models of haeme containing proteins, that also provide interesting and unusual porphyrin-ligand geometries[J]. Chem Commun (Camb), 2012, 48: 154-156.
[5]	Khan F, Singh K, Friedman MT. Artificial blood: the history and current perspectives of blood substitutes[J]. Discoveries (Craiova), 2020, 8: e104. doi:10.15190/d.2020.1
[6]	Keipert PE. MP4CO-SCD-105 study investigators. Clinical evaluation of MP4CO: a phase 1b escalating-dose, safety and tolerability study in stable adult patients with sickle cell disease[J]. Adv Exp Med Biol, 2016, 923: 23-29.
[7]	杨康, 赵会民, 樊毫军, 等. 聚多巴胺修饰蚯蚓血红蛋白纳米氧载体的构建及性能检测[J]. 中国组织工程研究, 2022, 26: 3369-3374.
[8]	Estep TN. HemAssist: development, clinical trials, lessons learned[M]//Liu H, Kaye AD, Jahr JS. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing, 2022: 287-292.
[9]	Wang A, Singh S, Yu B, et al. Cross-linked hemoglobin bis-tetramers from bioorthogonal coupling do not induce vasoconstriction in the circulation[J]. Transfusion, 2019, 59: 359-370.
[10]	Williams AT, Muller CR, Eaker AM, et al. Polymerized hemoglobin with increased molecular size reduces toxicity in healthy guinea pigs[J]. ACS Appl Bio Mater, 2020, 3: 2976-2985.
[11]	Belcher DA, Munoz C, Pires IS, et al. Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin[J]. Blood Adv, 2020, 4: 2739-2750.
[12]	Banerjee U, Wolfe S, O'Boyle Q, et al. Scalable production and complete biophysical characterization of poly(ethylene glycol) surface conjugated liposome encapsulated hemoglobin (PEG-LEH)[J]. PLoS One, 2022, 17: e0269939. doi:10.1371/journal.pone.0269939.
[13]	Lambert E, Janjic JM. Quality by design approach identifies critical parameters driving oxygen delivery performance in vitro for perfluorocarbon based artificial oxy-gen carriers[J]. Sci Rep, 2021, 11: 5569.doi:10.1038/s41598-021-84076-1.
[14]	Wang S, Zhao H, Zhang H, et al. Analyses of erythropoiesis from embryonic stem cell-CD34+ and cord blood-CD34+ cells reveal mechanisms for defective expansion and enucleation of embryomic stem cell-erythroid cells[J]. J Cell Mol Med, 2022, 26: 2404-2416.
[15]	Park YJ, Jeon SH, Kim HK, et al. Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes[J]. J Transl Med, 2020, 18: 236.
[16]	May A, Ventura T, Fidanza A, et al. Modelling the erythroblastic island niche of dyserythropoietic anaemia type Ⅳ patients using induced pluripotent stem cells[J]. Front Cell Dev Biol, 2023, 11: 1148013.doi:10.3389/fcell.2023.1148013.
[17]	Wang B, Liu XM, Liu ZN, et al. Human hair follicle-derived mesenchymal stem cells: isolation, expansion, and differentiation[J]. World J Stem Cells, 2020, 12: 462-470.
[18]	Yuki Y, Hagisawa K, Kinoshita M, et al. Efficacy of resuscitative infusion with hemoglobin vesicles in rabbits with massive obstetric hemorrhage[J]. Cureus, 2021, 224: 398.e1-398.e11. doi:10.7759/cureus.45216
[19]	Okuda C, Sakai H. Effect of carbon monoxide administration using haemoglobin-vesicles on the hippocampal tissue[J]. Artif Cells Nanomed Biotechnol, 2022, 50: 1-9.
[20]	Wang W, Wang X, Tao F, et al. Fluorinated hyaluronic acid encapsulated perfluorocarbon nanoparticles as tumor-targeted oxygen carriers to enhance radiotherapy[J]. Mol Pharm, 2022, 19: 3948-3958.
[21]	Wu M, Chen C, Liu Z, et al. Regulating the bacterial oxygen microenvironment via a perfluorocarbon-conjugated bacteriochlorin for enhanced photodynamic antibacterial efficacy[J]. Acta Biomaterialia, 2022, 142: 242-252.
[22]	Zhang Y, Qiu N, Zhang Y, et al. Oxygen-carrying nanoparticle-based chemo-sonodynamic therapy for tumor suppression and autoimmunity activation[J]. Biomater Sci, 2021, 9: 3989-4004.
[23]	Jiang M, Qin B, Luo L, et al. A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief[J]. J Control Release, 2021, 335: 408-419.
[24]	Le Meur Y, Badet L, Essig M, et al. First-in-human use of a marine oxygen carrier (M101) for organ preservation: a safety and proof-of-principle study[J]. Am J Transplant, 2020, 20: 1729-1738.
[25]	Usuda H, Saito M, Ikeda H, et al. Assessment of synthetic red cell therapy for extremely preterm ovine fetuses maintained on an artificial placenta life-support plat-form[J]. Artif Organs, 2022, 46: 653-665.